Group One Trading
CRDL

Group One Trading’s Cardiol Therapeutics CRDL Stock Holding History

Group One Trading’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$388 Buy
+366
New +$463 ﹤0.01% 7330
2025
Q4 		– Sell
-1,534
Closed -$1.61K – 8269
2025
Q3 		$1.64K Sell
1,534
-6,179
-80% -$7.5K ﹤0.01% 7956
2025
Q2 		$10.5K Sell
7,713
-733
-9% -$853 ﹤0.01% 6689
2025
Q1 		$8.19K Buy
8,446
+3,139
+59% +$3.85K ﹤0.01% 6390
2024
Q4 		$6.79K Sell
5,307
-19,533
-79% -$32.9K ﹤0.01% 6288
2024
Q3 		$49.2K Sell
24,840
-3,452
-12% -$7.16K ﹤0.01% 4661
2024
Q2 		$57.1K Buy
28,292
+24,625
+672% +$52.3K ﹤0.01% 4423
2024
Q1 		$6.64K Hold
3,667
– – ﹤0.01% 6071
2023
Q4 		$3.08K Buy
3,667
+2,000
+120% +$1.7K ﹤0.01% 6689
2023
Q3 		$1.53K Buy
1,667
+1,666
+166,600% +$1.59K ﹤0.01% 7120
2023
Q2 		$1 Hold
1
– – ﹤0.01% 7572
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7314
2022
Q4 		$1 Buy
+1
New +$1 ﹤0.01% 7127

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Group One Trading's CRDL Position: Q2 2026 in Review

Group One Trading opened a new position in Cardiol Therapeutics (CRDL) in Q2 2026: 366 shares worth $388. The stake represents ﹤0.01% of the portfolio and ranks #7330 among its holdings. This is a return to the name: Group One Trading previously reported a position in CRDL as recently as Q3 2025.

Group One Trading first reported a position in CRDL in Q4 2022 and has held it in 13 quarters since. The position peaked at $57.1K in Q2 2024. 51 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

  • Group One Trading held 366 shares of Cardiol Therapeutics worth $388 as of Q2 2026.
  • Cardiol Therapeutics was a new Group One Trading position in Q2 2026.
  • Cardiol Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7330 holding.
  • Group One Trading first reported a position in Cardiol Therapeutics in Q4 2022 and has held it in 13 quarters since.
  • Group One Trading's Cardiol Therapeutics position peaked at $57.1K in Q2 2024.
  • 51 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.